THE POTENTIAL COVID – 19 VACCINE OF BIONTECH AND PFIZER ENTERS A LATE-STAGE HUMAN TRIAL

Highlights

• Up to 30,000 participants will be included in the trial
• They expect to submit it for final regulatory review by October, if successful

Pfizer and BioNTech began their late-stage human trial for a potential corona virus vaccine. The respective U.S. drug maker and German biotech companies said the same on Monday. The pharmaceutical companies race to win regulatory approva....